Can a Herpes Drug Slow Alzheimer’s?

(MedPage Today) — TORONTO — The antiviral agent valacyclovir demonstrated no benefit in early Alzheimer’s disease, the phase II VALAD trial showed.
On the primary outcome of change in Alzheimer’s Disease Assessment Scale-Cognitive subscale…